Interim results from AUS-PREDICT registry show a significant change in radiation treatment recommendations when using DCISionRT test
DCISionRT is a novel molecular test that assesses the 10-year risk of recurrence after Breast…
Browsing: GenesisCare
How can we make integrative oncology care work in regional areas?
Integrative oncology can best be described as patient-centred, evidence-based comprehensive cancer care that includes conventional…
Improving head and neck radiotherapy in developing countries in real-time
How can we optimise head and neck cancer treatments in developing countries? Can it be…
GenesisCare welcomes budget injection into diagnostic imaging, precision medicine, rural health workforce
GenesisCare, the largest provider of integrated cancer care in Australia, has today welcomed a raft…
Breast cancer breakthrough: GenesisCare launches Australian-first breast cancer biomarker test
GenesisCare is announcing that for the first time, Australian women with non-invasive breast cancer will…
Lutetium-177 PSMA radioligand therapy shows promise in metastatic castration-resistant prostate cancer
Radioligand therapy, using targeted prostate-specific membrane antigen (PSMA) compounds, is emerging as a promising treatment…